Department of Vascular Surgery, Baylor College of Medicine, Houston, TX, USA.
Surgery. 2013 May;153(5):673-82. doi: 10.1016/j.surg.2012.10.011. Epub 2012 Dec 24.
The objective of the study was to evaluate the effectiveness of antibiotic-based polymethylmethacrylate (ab-PMMA) beads in achieving wound sterilization and graft preservation in patients with vascular graft infections.
We reviewed 31 patients treated for 37 graft infections over the past 5 years using ab-PMMA beads in a single institution. All patients were started on broad-spectrum antibiotics and later switched to targeted therapy based on intraoperative cultures for at least 6 weeks. All patients underwent multiple planned wound explorations, debridements and washouts. Cultures were obtained each time. Decision to do formal closure depended on culture results and wound appearance. All wounds were closed with a muscle flap. The endpoints included wound sterilization, limb salvage, recurrence of infection, and graft preservation.
A total of 19 different organisms were cultured, and 48.6% of cases were polymicrobial, thereby accounting for a total of 60 isolates. The majority (n = 27) received a mix of tobramycin/vancomycin PMMA beads; vancomycin beads (n = 5); tobramycin beads (n = 1); and gentamicin/vancomycin beads (n = 4). Wound sterilization based on cultures was achieved in 32 of 34 wounds (94.1%). Of the cases, 5 underwent early graft removal, 3 with immediate reconstruction, and 1 case underwent a major amputation (2.7 %). Graft preservation was attempted in 32 cases (86.5%). No death occurred within 30 days. Limb salvage was achieved in 28 of the 32 preserved graft cases (87.5%) at a mean follow-up of 26 months (6 to 51 months). The long-term limb salvage rate for the cohort was 86.5%. Of the patients, 4 presented with recurrent graft infection and occlusion, causing acute limb ischemia and resulting in major amputation. The reinfection rate was 12.5% in the graft-preservation group and 11.4% in both the graft-preserved and the in situ replacement groups.
Sterilization of graft infection can be achieved with ab-PMMA beads followed by closure with muscle flap, resulting in an acceptable limb-salvage rate despite virulent or polymicrobial graft infection.
本研究旨在评估抗生素聚甲基丙烯酸甲酯(ab-PMMA)珠在血管移植物感染患者中实现伤口灭菌和移植物保存方面的有效性。
我们回顾了过去 5 年在一家机构中使用 ab-PMMA 珠治疗 37 例移植物感染的 31 例患者。所有患者均接受广谱抗生素治疗,随后根据术中培养结果进行至少 6 周的靶向治疗。所有患者均接受多次计划中的伤口探查、清创和冲洗。每次均获取培养物。是否进行正式闭合取决于培养物结果和伤口外观。所有伤口均用肌肉瓣闭合。终点包括伤口灭菌、肢体保存、感染复发和移植物保存。
共培养出 19 种不同的病原体,其中 48.6%为混合感染,共培养出 60 株。大多数(n = 27)接受妥布霉素/万古霉素 PMMA 珠治疗;万古霉素珠(n = 5);妥布霉素珠(n = 1);和庆大霉素/万古霉素珠(n = 4)。根据培养物,34 个伤口中的 32 个(94.1%)实现了伤口灭菌。其中 5 例早期移植物切除,3 例立即重建,1 例进行大截肢(2.7%)。尝试保存 32 例移植物(86.5%)。30 天内无死亡。在 26 个月的平均随访时间(6 至 51 个月)内,保留的 32 例移植物中有 28 例(87.5%)实现了肢体保存。该队列的长期肢体保存率为 86.5%。4 例患者出现复发性移植物感染和闭塞,导致急性肢体缺血,最终进行大截肢。保肢组的再感染率为 12.5%,保肢组和原位替代组的再感染率均为 11.4%。
使用 ab-PMMA 珠进行移植物感染的灭菌,然后用肌肉瓣闭合,可实现可接受的肢体保存率,即使是毒力强或混合感染的移植物感染也是如此。